临床试验/NCT07032337

NCT07032337已完成不适用

Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder: A Target Trial Emulation Study

Samsung Medical Center0 个研究点目标入组 2,985 人开始时间: 2011年1月1日最近更新: 2025年6月23日

试验速览

阶段: 不适用
状态: 已完成
发起方: Samsung Medical Center
入组人数: 2,985
主要终点: Relapse

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

Newly diagnosed NMOSD patients

详细描述

From 2011 to 2022, newly diagnosed NMOSD patients who had not previously claimed NMOSD. Exclusion criteria were history of cancer or had used ISTs (excluding steroids) prior to the NMOSD diagnosis.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

性别: All
接受健康志愿者: 否

入选标准

•From 2011 to 2022, newly diagnosed NMOSD patients..

排除标准

•Patients had a history of cancer
•Patients had used ISTs (excluding steroids) prior to the NMOSD diagnosis.

结局指标

主要结局

Relapse

时间窗: 1 year

Relapses were identified when patients were treated with one of the following interventions: intravenous steroids, immunoglobulin therapy, or plasma exchange.

次要结局

Safety outcomes(6 months after start of ISTs)

研究者

发起方

Samsung Medical Center

申办方类型

Other

责任方

Principal Investigator

主要研究者

Ju-Hong Min

Professor

Samsung Medical Center

相似试验

尚未招募

2 期

Comparison of the Efficacy and Safety of Immunoadsorption and Plasma Exchange for Acute Attack of Refractory Neuromyelitis Optica Spectrum DisordersNeuromyelitis Optica Spectrum Disorder

NCT04064944Third Affiliated Hospital, Sun Yat-Sen University144

已完成

不适用

Efficacy of two type of immunosuppressive regimen in rate of graft rejection in the kidney transplant recipients

IRCT20160412027346N6Shahid Beheshti University of Medical Sciences46

已完成

Unknown

A compassionate use study of satralizumab in neuromyelitis optica spectrum disorders.(NMOSD) patientsneuromyelitis optica(NMO), neuromyelitis optica spectrum disorders (NMOSD)

JPRN-jRCT2080225027Chugai Pharmaceutical Co., Ltd.6

终止

4 期

Oral Prednisone Taper Versus Placebo for the Treatment of Acute Relapses in Multiple SclerosisMultiple Sclerosis

NCT01411514Claudio Gobbi27

进行中（未招募）

不适用

Study of immune deficiency patients treated with subcutaneous immunoglobulin (IgPro20, Hizentra®) on weekly and biweekly schedules

EUCTR2015-004977-34-Outside-EU/EEACSL Behring, LLC25